Get the Scoop: JLABS @ Toronto

Mar 
18
 | 
3:00pm
RSVPs Closed
Text goes here
X

Nilesh Kumar

Partner, Novo Ventures

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

Ticket
$0000
Ticket description
Day Month 0th 0:00pm
Day Month 0th 0:00pm
100 remaining

Nilesh Kumar

Partner, Novo Ventures

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

RSVPs Closed
Text goes here
X
3:00pm
–
4:00pm
July 
22
, 
2018

Get the Scoop:

JLABS @ Toronto

3:00 - 4:00 PM

ONRamp, University of Toronto

Banting Institute, RBC Innovation Hub

100 College St, Suite 150

Toronto, ON

M5G 1L5

3:00pm
–
4:00pm

Speaker

As the first JLABS to open outside the United States, JLABS @ Toronto joins a network of life science facilities that are based throughout the United States in San Diego (the flagship JLABS), San Francisco, Boston and Houston.

 

This facility is home to over 50 early-stage companies advancing pharmaceutical, medical device, consumer and digital health programs.

JLABS @ Toronto is located on the 13th floor in the MaRS West Tower and is a collaboration among Johnson & Johnson Innovation, The University of Toronto, MaRS Discovery District, Janssen Inc., MaRS Innovation, and the Government of Ontario. JLABS @ Toronto opened on May 11th, 2016, the 40,000-square foot facility includes cutting-edge, modular and scalable lab space, state-of-the-art equipment, with access to scientific, industry and capital funding experts.

 

The space also features JLABS' inaugural device and digital prototype lab that provides entrepreneurs with access to highly specialized tools and skills building programs to design and develop smart health technologies.

Overview

Since opening May 11th, 2016, JLABS @ Toronto now hosts over 48 companies in its space, with 15 alumni. JLABS @ Toronto offers emerging life science companies modular lab units, office space, shared core laboratory equipment and business facilities. It also links the entrepreneurs with the full breadth of Johnson & Johnson Innovation, including opportunities for funding, third-party services, educational events and R&D experts from medical technology, consumer healthcare product and Janssen pharmaceutical teams.
 

Come out and learn more about JLABS & how you can be a part of the ecosystem!

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due February 25, 2019. Apply Here.

Speakers

Allan Miranda

Head

JLABS @ Canada

As Head of Johnson & Johnson Innovation, JLABS in Canada, Allan is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. He catalyzes and supports the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer and healthtech sectors.

About
JLABS @ Toronto

As the first JLABS to open outside the United States, JLABS @ Toronto joins a network of life science facilities that are based throughout the United States in San Diego (the flagship JLABS), San Francisco, Boston and Houston.

 

This facility is home to 48 early-stage companies advancing pharmaceutical, medical device, consumer and digital health programs.


JLABS @ Toronto is located on the 13th floor in the MaRS West Tower and is a collaboration among Johnson & Johnson Innovation, The University of Toronto, MaRS Discovery District, Janssen Inc., MaRS Innovation, and the Government of Ontario. JLABS @ Toronto opened on May 11th, 2016, the 40,000-square foot facility includes cutting-edge, modular and scalable lab space, state-of-the-art equipment, with access to scientific, industry and capital funding experts.

 

The space also features JLABS' inaugural device and digital prototype lab that provides entrepreneurs with access to highly specialized tools and skills building programs to design and develop smart health technologies.

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due February 25, 2019. Apply Here.

Speaker

Bharat Srinivasa

Co-Founder and Associate
Amplitude Ventures

Mr. Bharat Srinivasa, Ph.D. serves as a Senior Analyst and previously served as an Analyst at BDC Venture Capital. Mr. Srinivasa joined BDC Capital in 2015. Before this, he was an Associate in the forecasting and valuation practice at Foster Rosenblatt, an international advisory firm focused exclusively on life sciences. He was responsible for providing forecasting, commercial analytics and pricing and market access analysis. He holds a Bachelor of Science in Biotechnology from the University of Toronto in 2008 and a Master of Science in Microbiology and Immunology from McGill University in 2010. He also completed his Ph.D. in Experimental Medicine at McGill University in 2014.

 

 

JLABS Event Partners

JLABS on Twitter

RSVPs are closed
Submit
Text goes here
X
Tickets closed
Submit
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
CONTACT THE ORGANIZER
Google   Outlook   iCal   Yahoo
Sorry, RSVPs have closed.